FULC Fulcrum Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 30, 2026
$3,69
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,8352-Wochen-Tief
$15,7452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$281M
P/E
-3.1
EPS
$-1.18
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$3–$16
Analystenbewertung
HOLD
Kursziel
$4
P/E
-3.1
ROE
-26.6%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
FULC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.69
Marktkapitalisierung (MRQ)
$281M
P/E
-3.1
EPS
$-1.18
Umsatz
$0
ROE
-26.6%
52W-Spanne
$3–$16
FULC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Fulcrum Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BranchePharmaceuticals
Mitarbeiter9
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02020-12-31 → 2025-12-31
EPS$-1.182020-12-31 → 2025-12-31
Freier Cashflow$-60M2019-12-31 → 2025-12-31
Nettogewinnmarge·2020-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | FULC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -3.15-Jahres-Durchschnitt ≈-10.8 | ≈-10.8 | · | · | |
| K/B (MRQ) | 0.95-Jahres-Durchschnitt ≈1.7 | ≈1.7 | 2.3 | Unterbewertet | |
| Kurs / FCF (TTM) | -4.35-Jahres-Durchschnitt ≈-30.6 | ≈-30.6 | · | · | |
| Kurs / Cashflow (TTM) | -4.35-Jahres-Durchschnitt ≈-33.8 | ≈-33.8 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.75-Jahres-Durchschnitt ≈2.1 | ≈2.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | FULC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -23.9%5-Jahres-Durchschnitt ≈-28.9% | ≈-28.9% | -34.8% | Spitzenklasse | |
| ROE | -26.6%5-Jahres-Durchschnitt ≈-30.6% | ≈-30.6% | -42.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | FULC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 31.45-Jahres-Durchschnitt ≈20.0 | ≈20.0 | 9.4 | Starke Liquidität | |
| Quick Ratio | 15.15-Jahres-Durchschnitt ≈6.1 | ≈6.1 | 4.5 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | FULC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 2752.0%5-Jahres-Durchschnitt ≈686.6% | ≈686.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 61.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | FULC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.2 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
5.0%
Nächster Bericht
Okt 27, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 27, 2026 | $-0.22 | $-0.22 | 2.0% |
| 31. März 2026 | $-0.25 | $-0.30 | 17.8% | |
| 31. Dezember 2025 | $-0.31 | $-0.32 | 1.7% | |
| 30. September 2025 | $-0.31 | $-0.30 | -3.5% | |
| 30. Juni 2025 | $-0.28 | $-0.30 | 5.3% | |
| 31. März 2025 | $-0.28 | $-0.30 | 6.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $80M | $3M | $6M | $19M | $9M | |
| R&D Expense | $56M | $63M | $72M | $77M | $70M | $59M | |
| SG&A Expense | $29M | $36M | $42M | $42M | $31M | $21M | |
| Operating Expenses | $85M | $102M | $113M | $119M | $100M | $80M | |
| Operating Income | $-85M | $-22M | $-111M | $-113M | $-81M | $-72M | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-75M | $-10M | $-97M | $-110M | $-81M | $-71M | |
| EPS (Basic) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 | |
| EPS (Diluted) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 | |
| Shares (Basic) | 63,355 | 61,984 | 61,310 | 44,991 | 35,361 | 25,354 | |
| Shares (Diluted) | 63,355 | 61,984 | 61,310 | 44,991 | 35,361 | 25,354 | |
| EBITDA | $-85M | $-22M | $-111M | $-113M | · | $-72M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $198M | $58M | $26M | $35M | $35M | $57M | |
| Prepaid Expense | $5M | $7M | $5M | $4M | $4M | $4M | |
| Other Current Assets | · | · | · | · | $0 | $74.0K | |
| Current Assets | $357M | $250M | $242M | $208M | $226M | $120M | |
| PP&E (Net) | $3M | $4M | $5M | $7M | $7M | $8M | |
| PP&E (Gross) | $18M | $18M | $18M | $18M | $16M | $15M | |
| Accum. Depreciation | $16M | $14M | $13M | $11M | $8M | $6M | |
| Other Non-current Assets | $538.0K | $10.0K | $2M | $2M | $542.0K | $578.0K | |
| Total Assets | $366M | $261M | $258M | $227M | $235M | $130M | |
| Accounts Payable | $2M | $1M | $3M | $4M | $5M | $4M | |
| Current Liabilities | $13M | $11M | $14M | $17M | $19M | $27M | |
| Capital Leases | $4M | $6M | $9M | $11M | $0 | · | |
| Other Non-current Liabilities | $197.0K | $197.0K | $197.0K | $197.0K | $0 | · | |
| Total Liabilities | $17M | $18M | $23M | $28M | $23M | $34M | |
| Common Stock | $67.0K | $54.0K | $62.0K | $52.0K | $41.0K | $28.0K | |
| Retained Earnings | $-594M | $-519M | $-510M | $-412M | $-302M | $-222M | |
| Treasury Stock | · | · | · | $0 | $0 | · | |
| AOCI | $174.0K | $130.0K | $-136.0K | $-797.0K | $-397.0K | $-2.0K | |
| Stockholders' Equity | $349M | $243M | $235M | $199M | $212M | $95M | |
| Liabilities + Equity | $366M | $261M | $258M | $227M | $235M | $130M | |
| Shares Outstanding | 66,578,891 | 53,968,303 | 61,915,367 | 52,099,211 | 40,626,224 | 27,941,566 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $12M | $15M | $15M | $13M | $11M | $7M | |
| Restructuring | $400.0K | $2M | · | $400.0K | · | · | |
| Operating Cash Flow | $-60M | $-2M | $-91M | $-97M | $-78M | $-54M | |
| CapEx | $314.0K | $278.0K | $508.0K | $2M | $2M | $1M | |
| Investing Cash Flow | $31M | $32M | $-37M | $12M | $-130M | $-57M | |
| Stock Issued | $4M | $3M | $777.0K | $4M | $4M | $1M | |
| Net Stock Activity | $4M | $3M | $777.0K | $4M | · | $1M | |
| Financing Cash Flow | $169M | $3M | $118M | $84M | $187M | $71M | |
| Net Change in Cash | $139M | $33M | $-10M | $-314.0K | $-22M | $-40M | |
| Free Cash Flow | $-60M | $-2M | $-91M | $-99M | · | $-55M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | -27.4% | -3945.2% | -1774.8% | · | -811.6% | |
| Net Margin | · | -12.2% | -3470.0% | -1732.4% | · | -802.7% | |
| EBITDA Margin | · | -27.4% | -3945.2% | -1774.8% | · | -811.6% | |
| ROA | -23.9% | -3.8% | -40.2% | -47.6% | · | -59.0% | |
| ROE | -26.6% | -3.9% | -39.7% | -52.3% | · | -70.8% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 27.4 | 22.6 | 17.7 | 12.4 | · | 4.5 | |
| Quick Ratio | 15.1 | 5.3 | 1.9 | 2.1 | · | 2.1 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.3 | 0.0 | 0.0 | · | 0.1 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.24 | $4.50 | $3.80 | $3.82 | · | $3.41 | |
| Revenue / Share | $0.00 | $1290.66 | $45.75 | $140.96 | · | · | |
| Cash Flow / Share | $-948.07 | $-35.78 | $-1483.69 | $-2157.10 | · | · | |
| Cash / Share | $2.97 | $1.08 | $0.41 | $0.67 | · | $2.04 | |
| EPS (TTM) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | 2752.0% | -55.8% | -66.9% | 117.2% | · | |
| Revenue CAGR 3Y | · | 61.0% | -31.8% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $80M | $3M | $6M | $19M | $9M | |
| Net Income TTM | $-75M | $-10M | $-97M | $-110M | $-81M | $-71M | |
| Market Cap | $753M | $254M | $418M | $379M | · | $327M | |
| P/E | -9.6 | -29.4 | -4.2 | -3.0 | -7.7 | -4.2 | |
| P/S | · | 3.2 | 149.0 | 59.8 | · | 37.1 | |
| P/B | 2.2 | 1.0 | 1.8 | 1.9 | · | 3.4 | |
| P / Tangible Book | 2.2 | 1.0 | 1.8 | 1.9 | 3.4 | 3.4 | |
| P / Cash Flow | -12.5 | -114.4 | -4.6 | -3.9 | · | -6.1 | |
| P / FCF | -12.5 | -101.6 | -4.6 | -3.8 | · | -5.9 | |
| Earnings Yield | -10.4% | -3.4% | -23.6% | -33.5% | -13.0% | -23.8% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $80M | $0 | $871.0K | $759.0K | $880.0K | $295.0K | $685.0K | $1M | |
| R&D Expense | $12M | $14M | $15M | $14M | $13M | $13M | $12M | $15M | $17M | $20M | $19M | $18M | $18M | $17M | $19M | $15M | |
| SG&A Expense | $7M | $8M | $7M | $8M | $7M | $7M | $8M | $8M | $10M | $10M | $10M | $10M | $10M | $12M | $10M | $10M | |
| Operating Expenses | $29M | $22M | $23M | $22M | $20M | $20M | $19M | $25M | $28M | $30M | $29M | $28M | $28M | $28M | $29M | $26M | |
| Operating Income | $-29M | $-22M | $-23M | $-22M | $-20M | $-20M | $-19M | $-25M | $52M | $-30M | $-28M | $-27M | $-27M | $-28M | $-28M | $-24M | |
| Net Income | $-26M | $-19M | $-20M | $-20M | $-17M | $-18M | $-17M | $-22M | $55M | $-27M | $-25M | $-24M | $-24M | $-25M | $-26M | $-24M | |
| EPS (Basic) | $-0.34 | $-0.25 | $-0.31 | $-0.31 | $-0.28 | $-0.28 | $-0.27 | $-0.35 | $0.89 | $-0.43 | $-0.41 | $-0.39 | $-0.38 | $-0.41 | $-0.46 | $-0.51 | |
| EPS (Diluted) | $-0.34 | $-0.25 | $-0.31 | $-0.31 | $-0.28 | $-0.28 | $-0.25 | $-0.35 | $0.87 | $-0.43 | $-0.41 | $-0.39 | $-0.38 | $-0.41 | $-0.46 | $-0.51 | |
| Shares (Basic) | 76,264,000 | 76,215,000 | · | 62,597,000 | 62,544,000 | 62,479,000 | · | 62,409,000 | 62,205,000 | 61,984,000 | · | 61,823,000 | 61,794,000 | 59,722 | · | 46,213 | |
| Shares (Diluted) | 76,264,000 | 76,215,000 | · | 62,597,000 | 62,544,000 | 62,479,000 | · | 62,409,000 | 63,587,000 | 61,984,000 | · | 61,823,000 | 61,794,000 | 59,722 | · | 46,213 | |
| EBITDA | $-29M | $-22M | · | $-22M | $-20M | $-20M | · | $-25M | $52M | $-30M | · | $-27M | $-27M | $-28M | · | $-24M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $50M | $198M | $47M | $43M | $42M | $58M | $73M | $87M | $40M | $26M | $30M | $34M | $35M | $35M | $91M | |
| Prepaid Expense | $4M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | $4M | $5M | $5M | $5M | $4M | $5M | $4M | $5M | |
| Other Current Assets | · | · | · | · | $69.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $323M | $339M | $357M | $206M | $219M | $233M | $250M | $267M | $280M | $218M | $242M | $262M | $283M | $303M | $208M | $228M | |
| PP&E (Net) | $0 | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $6M | $6M | $7M | $7M | $7M | |
| PP&E (Gross) | $1M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | |
| Accum. Depreciation | $1M | $15M | $16M | $15M | $15M | $15M | $14M | $14M | $14M | $13M | $13M | $12M | $12M | $11M | $11M | $10M | |
| Other Non-current Assets | $9.0K | $546.0K | $538.0K | $9.0K | $12.0K | $10.0K | $10.0K | $76.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $324M | $347M | $366M | $215M | $229M | $243M | $261M | $279M | $294M | $233M | $258M | $279M | $300M | $321M | $227M | $248M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $2M | $2M | $1M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $3M | |
| Current Liabilities | $10M | $10M | $13M | $12M | $9M | $8M | $11M | $15M | $13M | $11M | $14M | $14M | $15M | $14M | $17M | $15M | |
| Capital Leases | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | |
| Other Non-current Liabilities | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $447.0K | $320.0K | $197.0K | $197.0K | |
| Total Liabilities | $13M | $13M | $17M | $16M | $14M | $14M | $18M | $22M | $20M | $19M | $23M | $23M | $25M | $25M | $28M | $26M | |
| Common Stock | $76.0K | $67.0K | $67.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $62.0K | $62.0K | $62.0K | $62.0K | $62.0K | $62.0K | $52.0K | $52.0K | |
| Retained Earnings | $-639M | $-613M | $-594M | $-574M | $-554M | $-537M | $-519M | $-503M | $-481M | $-537M | $-510M | $-485M | $-461M | $-437M | $-412M | $-386M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | |
| AOCI | $-567.0K | $-513.0K | $174.0K | $241.0K | $82.0K | $70.0K | $130.0K | $379.0K | $-366.0K | $-434.0K | $-136.0K | $-886.0K | $-1M | $-651.0K | $-797.0K | $-921.0K | |
| Stockholders' Equity | $311M | $333M | $349M | $198M | $214M | $228M | $243M | $257M | $274M | $214M | $235M | $255M | $275M | $296M | $199M | $221M | |
| Liabilities + Equity | $324M | $347M | $366M | $215M | $229M | $243M | $261M | $279M | $294M | $233M | $258M | $279M | $300M | $321M | $227M | $248M | |
| Shares Outstanding | 76,285,157 | 66,608,096 | 66,578,891 | 54,108,438 | 54,091,588 | 53,979,306 | 53,968,303 | 53,938,661 | 62,250,631 | 62,141,011 | 61,915,367 | 52,099,211 | 52,099,211 | 61,758,994 | 52,099,211 | 52,049,913 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | |
| Restructuring | $4M | · | $400.0K | $0 | $0 | $0 | $2M | $0 | · | · | · | · | · | · | · | $400.0K | |
| Operating Cash Flow | $-16M | $-19M | $-17M | $-14M | $-14M | $-15M | $-17M | $-19M | $59M | $-25M | $-23M | $-23M | $-21M | $-24M | $-20M | $-28M | |
| CapEx | $108.0K | $8.0K | $159.0K | $90.0K | $65.0K | $0 | $231.0K | $19.0K | $0 | $28.0K | $77.0K | $65.0K | $195.0K | $171.0K | $116.0K | $283.0K | |
| Investing Cash Flow | $14M | $-128M | $-1M | $19M | $14M | $-777.0K | $2M | $4M | $-13M | $38M | $18M | $19M | $20M | $-94M | $-36M | $-2M | |
| Stock Issued | $356.0K | $21.0K | $4M | $64.0K | $301.0K | $0 | $83.0K | $635.0K | $377.0K | $2M | $287.0K | $0 | $142.0K | $348.0K | $267.0K | $93.0K | |
| Net Stock Activity | · | $21.0K | · | · | · | $0 | · | · | · | $2M | · | · | · | $348.0K | · | · | |
| Financing Cash Flow | $356.0K | $-312.0K | $168M | $64.0K | $301.0K | $0 | $83.0K | $635.0K | $377.0K | $2M | $287.0K | $0 | $142.0K | $118M | $218.0K | $81M | |
| Net Change in Cash | $-2M | $-147M | $150M | $4M | $414.0K | $-16M | $-14M | $-14M | $47M | $14M | $-5M | $-4M | $-768.0K | $-364.0K | $-56M | $51M | |
| Free Cash Flow | · | $-19M | · | · | · | $-15M | · | · | · | $-25M | · | · | · | $-24M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | 65.6% | · | · | -3615.3% | -3101.4% | -9471.2% | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | 69.3% | · | · | -3164.3% | -2702.6% | -8399.7% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | 65.6% | · | · | -3615.3% | -3101.4% | -9471.2% | · | · | |
| ROA | -9.5% | -6.4% | · | -7.9% | -6.6% | -7.4% | · | -7.8% | 22.6% | -10.1% | · | -9.1% | · | -9.2% | · | -9.4% | |
| ROE | -10.0% | -6.7% | · | -8.6% | -7.1% | -8.0% | · | -8.5% | 25.5% | -11.0% | · | -10.1% | · | -10.2% | · | -10.5% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.4 | 34.3 | · | 17.7 | 24.4 | 28.7 | · | 18.4 | 22.1 | 20.4 | · | 18.6 | · | 21.0 | · | 15.5 | |
| Quick Ratio | 4.7 | 5.1 | · | 4.0 | 4.7 | 5.2 | · | 5.0 | 6.8 | 3.7 | · | 2.1 | · | 2.4 | · | 6.2 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.3 | 0.0 | · | 0.0 | · | 0.0 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.07 | $5.00 | · | $3.67 | $3.96 | $4.23 | · | $4.77 | $4.40 | $3.44 | · | $4.90 | · | $4.80 | · | $4.25 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | · | · | $0.00 | $1.26 | $0.00 | · | $12.28 | $14.24 | $4.94 | · | · | |
| Cash Flow / Share | · | $-0.25 | · | · | · | $-0.24 | · | · | · | $-407.91 | · | · | · | $-403.80 | · | · | |
| Cash / Share | $0.64 | $0.75 | · | $0.87 | $0.79 | $0.78 | · | $1.35 | $1.39 | $0.64 | · | $0.58 | · | $0.56 | · | $1.75 | |
| EPS (TTM) | $-1.21 | $-1.15 | · | $-1.12 | $-1.16 | $-0.01 | · | $-0.32 | $-0.36 | $-1.61 | · | $-1.64 | $-1.76 | $-2.21 | · | $-2.56 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $80M | · | $81M | $82M | $3M | · | $3M | $3M | $4M | · | $11M | |
| Net Income TTM | $-85M | $-76M | · | $-71M | $-73M | $-510.0K | · | $-18M | $-20M | $-99M | · | $-99M | $-98M | $-109M | · | $-107M | |
| Market Cap | $279M | $511M | · | $498M | $372M | $155M | · | $193M | $386M | $587M | · | $231M | · | $176M | · | $421M | |
| P/E | -3.0 | -6.7 | · | -8.2 | -5.9 | -288.0 | · | -11.2 | -17.2 | -5.9 | · | -2.7 | -1.9 | -1.3 | · | -3.2 | |
| P/S | · | · | · | · | · | 1.9 | · | 2.4 | 4.7 | 233.7 | · | 88.3 | · | 43.5 | · | 39.3 | |
| P/B | 0.9 | 1.5 | · | 2.5 | 1.7 | 0.7 | · | 0.7 | 1.4 | 2.7 | · | 0.9 | · | 0.6 | · | 1.9 | |
| P / Tangible Book | 0.9 | 1.5 | · | 2.5 | 1.7 | 0.7 | · | 0.7 | 1.4 | 2.7 | · | 0.9 | · | 0.6 | · | 1.9 | |
| P / Cash Flow | · | -27.2 | · | · | · | -10.2 | · | · | · | -23.2 | · | · | · | -7.3 | · | · | |
| Earnings Yield | -33.1% | -15.0% | · | -12.2% | -16.9% | -0.35% | · | -9.0% | -5.8% | -17.1% | · | -36.9% | -53.3% | -77.5% | · | -31.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $0 | $80M | $3M | $6M | $19M |
| Betriebsgewinnmarge % | · | -27.4% | -3945.2% | -1774.8% | · |
| Nettoergebnis | $-75M | $-10M | $-97M | $-110M | $-81M |
| Verwässerte EPS | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 27.4 | 22.6 | 17.7 | 12.4 | · |
| Quick Ratio | 15.1 | 5.3 | 1.9 | 2.1 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-60M | $-2M | $-91M | $-99M | · |
Institutionelle Eigentümer (13F) 167 Einreicher · $328.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
167
Gehaltener Wert
$328.0M
Neue Positionen
30
Geschlossene Positionen
40
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 30 (-8 vs. Vorquartal) | 40 (+4 vs. Vorquartal) | 75 (0 vs. Vorquartal) | 35 (-4 vs. Vorquartal) | +7.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $40.258.533 | 3.559.552 | 12,28% | Aktien |
| BlackRock, Inc. | $32.296.788 | 8.824.259 | 9,85% | Aktien |
| EcoR1 Capital, LLC | $23.972.510 | 6.549.866 | 7,31% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $23.868.368 | 6.521.412 | 7,28% | Aktien |
| Nantahala Capital Management, LLC | $20.038.646 | 5.475.040 | 6,11% | Aktien |
| MONTANOVA CAPITAL, LLC | $13.472.171 | 3.680.921 | 4,11% | Aktien |
| D. E. Shaw & Co., Inc. | $11.142.449 | 3.044.385 | 3,40% | Aktien |
| CITADEL ADVISORS LLC | $9.898.488 | 2.704.505 | 3,02% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.871.811 | 2.697.216 | 3,01% | Aktien |
| JANE STREET GROUP, LLC | $8.116.043 | 2.217.498 | 2,47% | Aktien |
| STATE STREET CORP | $7.455.512 | 2.037.025 | 2,27% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.320.000 | 2.000.000 | 2,23% | Aktien |
| GSK plc | $6.535.713 | 1.785.714 | 1,99% | Aktien |
| Qube Research & Technologies Ltd | $6.399.389 | 1.748.467 | 1,95% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $6.030.948 | 1.647.800 | 1,84% | Aktien |
| ADAR1 Capital Management, LLC | $5.728.006 | 1.565.029 | 1,75% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $5.438.039 | 1.485.803 | 1,66% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $5.242.680 | 1.432.133 | 1,60% | Aktien |
| MARSHALL WACE, LLP | $4.971.828 | 1.358.423 | 1,52% | Aktien |
| UBS Group AG | $4.589.307 | 1.253.909 | 1,40% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.322.262 | 1.180.946 | 1,32% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $4.037.935 | 1.103.261 | 1,23% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.005.595 | 1.094.425 | 1,22% | Aktien |
| Ikarian Capital, LLC | $3.839.929 | 1.049.161 | 1,17% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.817.486 | 1.043.029 | 1,16% | Aktien |
| Jump Financial, LLC | $3.678.300 | 1.005.000 | 1,12% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $3.515.976 | 960.547 | 1,07% | Aktien |
| Assenagon Asset Management S.A. | $3.056.847 | 835.204 | 0,93% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.974.724 | 812.766 | 0,91% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.862.647 | 782.144 | 0,87% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $2.727.860 | 745.317 | 0,83% | Aktien |
| Balyasny Asset Management L.P. | $2.534.082 | 692.372 | 0,77% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $2.495.505 | 681.832 | 0,76% | Aktien |
| Point72 Asset Management, L.P. | $2.384.223 | 651.427 | 0,73% | Aktien |
| NORTHERN TRUST CORP | $1.785.600 | 487.869 | 0,54% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.585.585 | 433.220 | 0,48% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.265.072 | 345.648 | 0,39% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.112.596 | 303.988 | 0,34% | Aktien |
| Peapod Lane Capital LLC | $1.046.021 | 285.798 | 0,32% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.043.408 | 285.084 | 0,32% | Aktien |
| Engineers Gate Manager LP | $885.720 | 242.000 | 0,27% | Aktien |
| EntryPoint Capital, LLC | $794.948 | 217.199 | 0,24% | Aktien |
| XTX Topco Ltd | $765.844 | 209.247 | 0,23% | Aktien |
| CITADEL ADVISORS LLC | $743.712 | 203.200 | 0,23% | Verkaufsoption |
| Quadrature Capital Ltd | $692.176 | 189.119 | 0,21% | Aktien |
| MORGAN STANLEY | $674.143 | 184.192 | 0,21% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $641.964 | 175.400 | 0,20% | Verkaufsoption |
| ALLIANCEBERNSTEIN L.P. | $639.448 | 83.370 | 0,19% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $570.477 | 155.868 | 0,17% | Aktien |
| Nuveen, LLC | $566.828 | 154.871 | 0,17% | Aktien |
Unternehmensinsider 29 Insider · 13 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Alex Sapir | President & Chief Executive Officer | 2. Februar 2026 A | 193.360 | 0 | 0 | $0 |
| Bryan Stuart | President & Chief Executive Officer | 19. Januar 2022 A | 0 | 0 | 0 | $0 |
| Esther Rajavelu | Chief Financial Officer | 9. Februar 2023 A | · | 0 | 0 | $0 |
| Judith Dunn | President, Research & Development | 19. Januar 2022 A | · | 0 | 0 | $0 |
| Melvin H. Hayes III | Chief Operating Officer | 26. April 2023 A | · | 0 | 0 | $0 |
| Greg Tourangeau | Principal Accounting Officer | 2. Februar 2026 A | 14.062 | 0 | 0 | $0 |
| Curtis Gale Oltmans | Chief Legal Officer | 2. Februar 2026 A | 10.252 | 0 | 1 | $-44.600 |
| Patrick Taylor Horn | Chief Medical Officer | 18. März 2024 A | · | 0 | 0 | $0 |
| Santiago Arroyo | Chief Medical Officer | 7. November 2022 A | · | 0 | 0 | $0 |
| Christopher Morabito | Chief Medical Officer | 19. Januar 2022 A | 1.100 | 0 | 0 | $0 |
| Christopher Moxham | Chief Scientific Officer | 10. August 2021 M | 0 | 0 | 0 | $0 |
| Owen B. Wallace | Chief Scientific Officer | 14. September 2020 M | 133.438 | 0 | 0 | $0 |
| Diego Cadavid | SVP Clinical Development | 1. Juli 2020 S | 65.714 | 0 | 0 | $0 |
| Sonja Banks | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
| Alan Ezekowitz | Direktor | 30. Juni 2026 A | 10.927 | 0 | 1 | $-65.700 |
| Colin Hill | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
| Kate Haviland | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
| Katina Dorton | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
| Rachel K. King | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
| Robert J Gould | Direktor | 30. Juni 2026 A | 469.864 | 0 | 4 | $-667.350 |
| James A Geraghty | Direktor | 30. Juni 2026 A | 90.714 | 0 | 0 | $0 |
| Joshua Lehrer-Graiwer | Direktor | 23. April 2026 A | · | 0 | 0 | $0 |
| James J. Collins | Direktor | 17. Juni 2024 A | · | 0 | 0 | $0 |
| Mark J Levin | Direktor | 10. November 2021 J | 3.962.202 | 0 | 0 | $0 |
| 6 Dimensions Capital, L.P. | 10%-Eigentümer | 22. Juli 2019 C | 559.821 | 0 | 0 | $0 |
| GSK plc | 10%-Eigentümer | 22. Juli 2019 C | 1.785.714 | 0 | 0 | $0 |
| Sanofi | 10%-Eigentümer | 22. Juli 2019 C | 558.035 | 0 | 0 | $0 |
| Alan A Musso | · | 2. Februar 2026 A | · | 0 | 0 | $0 |
| Peter G. Thomson | · | 19. Januar 2022 A | 2.300 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 20 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,50% | 29.016 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 202.049 SH | 10. September 2026 | Täglich |
| IBB · iShares Trust | 0,02% | 555.962 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 5.408 SH | 1. Oktober 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 105.748 SH | 30. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,01% | 53.282 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 341.378 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 50.849 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.524.331 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 28.359 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 54.992 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 93.958 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 110.448 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 23.393 SH | 3. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 10.048 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 553.375 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.074.332 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.108 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 140.406 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 564.368 SH | 11. September 2026 | Täglich |
FULC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
VERKAUF
Median-Ziel
$4.00
+8,4%
0 0,0%
Starker Kauf
0 0,0%
Kauf
7 63,6%
Halten
2 18,2%
Verkauf
2 18,2%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-09-20Mittelwert-Ziel $3.67 -0,6%
Jetzt
Aktueller Preis $3.69
Tief$3.00
Mittelwert$3.67
Hoch$4.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 30, 2026